Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001346302-19-000019
Filing Date
2019-05-09
Accepted
2019-05-09 17:03:46
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q q12019form10-q.htm 10-Q 1240944
2 EXHIBIT 10.1 q12019exhibit101.htm EX-10.1 39861
3 EXHIBIT 31.1 q12019exhibit311.htm EX-31.1 13586
4 EXHIBIT 31.2 q12019exhibit312.htm EX-31.2 13667
5 EXHIBIT 32.1 q12019exhibit321.htm EX-32.1 10476
  Complete submission text file 0001346302-19-000019.txt   4796054

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xers-20190331.xml EX-101.INS 794272
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20190331.xsd EX-101.SCH 37941
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20190331_cal.xml EX-101.CAL 27211
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20190331_def.xml EX-101.DEF 202275
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20190331_lab.xml EX-101.LAB 462614
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20190331_pre.xml EX-101.PRE 282941
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

EIN.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38536 | Film No.: 19811586
SIC: 2834 Pharmaceutical Preparations